What is Doctolib?
Founded in 2013, Doctolib has evolved into a cornerstone of the digital health sector. The platform provides a comprehensive suite of tools that streamline the interaction between medical practitioners and patients, including online appointment scheduling, teleconsultation services, and practice management software. By digitizing the administrative and clinical workflows of healthcare providers, Doctolib addresses critical inefficiencies in the medical sector. Its market position is characterized by high adoption rates among doctors and a user-friendly interface that has become synonymous with modern patient access in France and beyond. The company operates at the intersection of enterprise SaaS and healthcare delivery, positioning itself as a vital utility in the ongoing digital transformation of European medical services.
How much funding has Doctolib raised?
Doctolib has raised a total of $813.9M across 7 funding rounds:
Angel/Seed
$1.2M
Series A
$4.9M
Series B
$20M
Series C
$28M
Private Equity
$42M
Unspecified
$170M
Other Financing Round
$547.8M
Angel/Seed (2014): $1.2M, investors not publicly disclosed
Series A (2014): $4.9M, investors not publicly disclosed
Series B (2015): $20M supported by Accel Partners
Series C (2017): $28M featuring Accel and Bpifrance
Private Equity (2017): $42M backed by Eurazeo and Bpifrance
Unspecified (2019): $170M with participation from Kernel, Eurazeo, Bpifrance, General Atlantic, and Accel
Other Financing Round (2022): $547.8M led by Eurazeo, Bpifrance, and General Atlantic
Key Investors in Doctolib
Eurazeo
Headquartered in Paris, Eurazeo is a leading global investment company with considerable private equity, venture capital, real estate, and private debt, offering deep sector expertise and a gateway to global markets for transformational growth.
Bpifrance
Founded in 2012, Bpifrance is a French public investment bank that finances companies at every stage of their development with credit, guarantees, and equity to support innovation and international expansion.
General Atlantic
General Atlantic is a global growth equity firm that provides capital and strategic support to high-growth companies in sectors such as healthcare and technology, partnering with management teams to accelerate international scale.
What's next for Doctolib?
With the infusion of this latest capital, Doctolib is well-positioned to accelerate its strategic initiatives, focusing on deepening its product integration and expanding its footprint in international markets. The company is expected to prioritize the enhancement of its teleconsultation capabilities and the development of advanced data-driven tools for healthcare providers. As it moves into this next phase of growth, the firm will likely leverage its strong institutional backing to navigate the complexities of regional healthcare regulations while scaling its operations to meet the rising demand for integrated digital health solutions. The focus remains on maintaining its leadership in the European market while exploring new avenues for operational efficiency and patient-centric innovation.
See full Doctolib company page
